19.37 USD
-1.3 (-6.29%)
19.74 USD
+0.37 (+1.91%)
Overall SMLR gets a fundamental rating of 4 out of 10. We evaluated SMLR against 185 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of SMLR while its profitability can be described as average. SMLR has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year SMLR was profitable.
SMLR had a negative operating cash flow in the past year.
Each year in the past 5 years SMLR has been profitable.
SMLR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of SMLR (8.10%) is better than 89.19% of its industry peers.
The Return On Equity of SMLR (10.51%) is better than 87.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.1% | ||
| ROE | 10.51% | ||
| ROIC | N/A |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SMLR has a Profit Margin of 130.80%. This is amongst the best in the industry. SMLR outperforms 99.46% of its industry peers.
SMLR's Profit Margin has improved in the last couple of years.
In the last couple of years the Operating Margin of SMLR has grown nicely.
Looking at the Gross Margin, with a value of 90.83%, SMLR belongs to the top of the industry, outperforming 97.30% of the companies in the same industry.
In the last couple of years the Gross Margin of SMLR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 130.8% | ||
| GM | 90.83% |
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
SMLR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SMLR has more shares outstanding
SMLR has more shares outstanding than it did 5 years ago.
There is no outstanding debt for SMLR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
SMLR has an Altman-Z score of 1.74. This is a bad value and indicates that SMLR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.74, SMLR is in line with its industry, outperforming 55.68% of the companies in the same industry.
SMLR has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.25, SMLR perfoms like the industry average, outperforming 54.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.74 |
ROIC/WACCN/A
WACC9.81%
2.3 Liquidity
SMLR has a Current Ratio of 1.97. This is a normal value and indicates that SMLR is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.97, SMLR is not doing good in the industry: 61.08% of the companies in the same industry are doing better.
SMLR has a Quick Ratio of 1.95. This is a normal value and indicates that SMLR is financially healthy and should not expect problems in meeting its short term obligations.
SMLR's Quick ratio of 1.95 is in line compared to the rest of the industry. SMLR outperforms 54.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.97 | ||
| Quick Ratio | 1.95 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 220.88% over the past year.
SMLR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.17% yearly.
SMLR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -37.30%.
Measured over the past years, SMLR shows a quite strong growth in Revenue. The Revenue has been growing by 11.43% on average per year.
EPS 1Y (TTM)220.88%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%48.61%
Revenue 1Y (TTM)-37.3%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.56%
3.2 Future
Based on estimates for the next years, SMLR will show a very negative growth in Earnings Per Share. The EPS will decrease by -29.01% on average per year.
Based on estimates for the next years, SMLR will show a very negative growth in Revenue. The Revenue will decrease by -16.29% on average per year.
EPS Next Y-95.59%
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue Next Year-43.2%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 2.21, which indicates a rather cheap valuation of SMLR.
Based on the Price/Earnings ratio, SMLR is valued cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.19. SMLR is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 237.38 indicates a quite expensive valuation of SMLR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SMLR indicates a somewhat cheap valuation: SMLR is cheaper than 65.41% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.88, SMLR is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.21 | ||
| Fwd PE | 237.38 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The decent profitability rating of SMLR may justify a higher PE ratio.
A cheap valuation may be justified as SMLR's earnings are expected to decrease with -29.01% in the coming years.
PEG (NY)N/A
PEG (5Y)0.09
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
5. Dividend
5.1 Amount
No dividends for SMLR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
19.37
-1.3 (-6.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners65.81%
Inst Owner Change0%
Ins Owners4.75%
Ins Owner Change0%
Market Cap293.65M
Revenue(TTM)36.96M
Net Income(TTM)48.34M
Analysts82.22
Price Target66.98 (245.79%)
Short Float %20.65%
Short Ratio4.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1964.05%
Min EPS beat(2)1930.07%
Max EPS beat(2)1998.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.59%
Min Revenue beat(2)-6.63%
Max Revenue beat(2)-0.56%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.83%
PT rev (3m)-12.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)118.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.21 | ||
| Fwd PE | 237.38 | ||
| P/S | 7.95 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.64 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)8.76
EY45.22%
EPS(NY)0.08
Fwd EY0.42%
FCF(TTM)-1.79
FCFYN/A
OCF(TTM)-1.78
OCFYN/A
SpS2.44
BVpS30.33
TBVpS-5.28
PEG (NY)N/A
PEG (5Y)0.09
Graham Number77.31
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.1% | ||
| ROE | 10.51% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 130.8% | ||
| GM | 90.83% | ||
| FCFM | N/A |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)23.58%
ROCE(5y)33.24%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
F-Score2
Asset Turnover0.06
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 55.77% | ||
| Cap/Sales | 0.63% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.97 | ||
| Quick Ratio | 1.95 | ||
| Altman-Z | 1.74 |
F-Score2
WACC9.81%
ROIC/WACCN/A
Cap/Depr(3y)171.05%
Cap/Depr(5y)155.18%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.73%
Profit Quality(3y)88.64%
Profit Quality(5y)91.36%
High Growth Momentum
Growth
EPS 1Y (TTM)220.88%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%48.61%
EPS Next Y-95.59%
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-37.3%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.56%
Revenue Next Year-43.2%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
EBIT growth 1Y-126.25%
EBIT growth 3Y2.48%
EBIT growth 5Y14.34%
EBIT Next Year-354.87%
EBIT Next 3Y-51.48%
EBIT Next 5YN/A
FCF growth 1Y-262.46%
FCF growth 3Y16.95%
FCF growth 5Y17.17%
OCF growth 1Y-244.7%
OCF growth 3Y14.98%
OCF growth 5Y13.91%
SEMLER SCIENTIFIC INC / SMLR FAQ
What is the ChartMill fundamental rating of SEMLER SCIENTIFIC INC (SMLR) stock?
ChartMill assigns a fundamental rating of 4 / 10 to SMLR.
Can you provide the valuation status for SEMLER SCIENTIFIC INC?
ChartMill assigns a valuation rating of 4 / 10 to SEMLER SCIENTIFIC INC (SMLR). This can be considered as Fairly Valued.
How profitable is SEMLER SCIENTIFIC INC (SMLR) stock?
SEMLER SCIENTIFIC INC (SMLR) has a profitability rating of 6 / 10.
What is the financial health of SEMLER SCIENTIFIC INC (SMLR) stock?
The financial health rating of SEMLER SCIENTIFIC INC (SMLR) is 3 / 10.